Neoadjuvant TP (Cisplatin-Docetaxel) for patients unfit to TPF (Cisplatin-Docetaxel-5FU) in locally advanced head and neck squamous cell cancer (LAHNSCC): an exploratory study on 14 patients
Otorhinolaryngology-head and neck surgery